Bio Green Med Solution, Inc. — Director's Dealing 2015

Dec 9, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2015-12-07

Reporting Person: Rombotis Spiro George (Director, President & C.E.O.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-07	Option	$0.589	A	437569	Acquired	2025-12-07	Common Stock (437569)	Direct

Footnotes

F1: These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.

F2: These securities were granted to Mr. Rombotis under the Issuer's 2015 Equity Incentive Plan as part of the Issuer's annual compensation review to executive officers.